{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:13:20Z","timestamp":1790907200489,"version":"4.1.0"},"reference-count":52,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,7,31]]},"DOI":"10.1097\/qad.0b013e328347b5e2","type":"journal-article","created":{"date-parts":[[2011,4,19]],"date-time":"2011-04-19T10:34:39Z","timestamp":1303209279000},"page":"1443-1453","source":"Crossref","is-referenced-by-count":17,"title":["CD4+ T-cell differentiation, regulatory T cells and gag-specific T lymphocytes are unaffected by CD4-guided treatment interruption and therapy resumption"],"prefix":"10.1097","volume":"25","author":[{"given":"Elisa","family":"Nemes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lugli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Bertoncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milena","family":"Nasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Pinti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Manzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Prati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Manzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Del Giovane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"D\u2019Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Cossarizza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Mussini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-1-20210130","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/01.qai.0000233310.90484.16","article-title":"Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study.","volume":"43","author":"Palella","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R2-1-20210130","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/157016208784324976","article-title":"Mortality and morbidity of HIV infected patients receiving HAART: a cohort study.","volume":"6","author":"Panos","year":"2008","journal-title":"Curr HIV Res"},{"key":"R3-1-20210130","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2337\/dc06-1075","article-title":"Prevalence of metabolic syndrome in HIV-infected patients receiving highly active antiretroviral therapy using International Diabetes Foundation and Adult Treatment Panel III criteria: associations with insulin resistance, disturbed body fat compartmentalization, elevated C-reactive protein, and corrected hypoadiponectinemia.","volume":"30","author":"Samaras","year":"2007","journal-title":"Diabetes Care"},{"key":"R4-1-20210130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00001432-200102000-00006","article-title":"Structured treatment interruptions in antiretroviral management of HIV-1.","volume":"14","author":"Miller","year":"2001","journal-title":"Curr Opin Infect Dis"},{"key":"R5-1-20210130","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1056\/NEJM200102153440702","article-title":"Virologic and immunologic consequences of discontinuing combination antiretroviral-drug therapy in HIV-infected patients with detectable viremia.","volume":"344","author":"Deeks","year":"2001","journal-title":"N Engl J Med"},{"key":"R6-1-20210130","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1056\/NEJM199905273402114","article-title":"Control of HIV despite the discontinuation of antiretroviral therapy.","volume":"340","author":"Lisziewicz","year":"1999","journal-title":"N Engl J Med"},{"key":"R7-1-20210130","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/35035103","article-title":"Immune control of HIV-1 after early treatment of acute infection.","volume":"407","author":"Rosenberg","year":"2000","journal-title":"Nature"},{"key":"R8-1-20210130","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/COH.0b013e3282f54cde","article-title":"Treatment interruption as a tool to measure changes in immunologic response to HIV-1.","volume":"3","author":"Kutzler","year":"2008","journal-title":"Curr Opin HIV AIDS"},{"key":"R9-1-20210130","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/00002030-200207260-00013","article-title":"Kinetics of CD4 cells after discontinuation of antiretroviral therapy in patients with virological failure and a CD4 cell count greater than 500cellsmicrol.","volume":"16","author":"Mussini","year":"2002","journal-title":"AIDS"},{"key":"R10-1-20210130","first-page":"287","article-title":"CD4 cell-monitored treatment interruption in patients with a CD4 cell count500x106cellsl.","volume":"19","author":"Mussini","year":"2005","journal-title":"AIDS"},{"key":"R11-1-20210130","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S0140-6736(06)69153-8","article-title":"CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial.","volume":"368","author":"Ananworanich","year":"2006","journal-title":"Lancet"},{"key":"R12-1-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/00002030-200402200-00010","article-title":"Effect of prolonged discontinuation of successful antiretroviral therapy on CD4 T cells: a controlled, prospective trial.","volume":"18","author":"Maggiolo","year":"2004","journal-title":"AIDS"},{"key":"R13-1-20210130","first-page":"2381","article-title":"CD4 cell-count-guided treatment interruptions in chronic HIV-infected patients with good response to highly active antiretroviral therapy.","volume":"18","author":"Boschi","year":"2004","journal-title":"AIDS"},{"key":"R14-1-20210130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1002\/jmv.21424","article-title":"Prognostic factors of long-term CD4 count-guided interruption of antiretroviral treatment.","volume":"81","author":"Sarmati","year":"2009","journal-title":"J Med Virol"},{"key":"R15-1-20210130","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1097\/QAD.0b013e328321b75e","article-title":"CD4 cell-guided scheduled treatment interruptions in HIV-infected patients with sustained immunologic response to HAART.","volume":"23","author":"Maggiolo","year":"2009","journal-title":"AIDS"},{"key":"R16-1-20210130","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1056\/NEJMoa062360","article-title":"CD4 count-guided interruption of antiretroviral treatment.","volume":"355","author":"El-Sadr","year":"2006","journal-title":"N Engl J Med"},{"key":"R17-1-20210130","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1086\/529523","article-title":"Inferior clinical outcome of the CD4 cell count-guided antiretroviral treatment interruption strategy in the SMART study: role of CD4 Cell counts and HIV RNA levels during follow-up.","volume":"197","author":"Lundgren","year":"2008","journal-title":"J Infect Dis"},{"key":"R18-1-20210130","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1086\/512681","article-title":"Interruption of antiretroviral treatment in HIV-infected patients with preserved immune function is associated with a low rate of clinical progression: a prospective study by AIDS Clinical Trials Group 5170.","volume":"195","author":"Skiest","year":"2007","journal-title":"J Infect Dis"},{"key":"R19-1-20210130","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/QAD.0b013e328011033a","article-title":"Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.","volume":"21","author":"Ruiz","year":"2007","journal-title":"AIDS"},{"key":"R20-1-20210130","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1097\/01.aids.0000247575.41622.b1","article-title":"Immunophenotype of HIV patients during CD4 cell-monitored treatment interruption: role of the IL-7IL-7 receptor system.","volume":"20","author":"Nemes","year":"2006","journal-title":"AIDS"},{"key":"R21-1-20210130","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/QAI.0b013e3181b9e94d","article-title":"Magnitude and determinants of CD4 recovery after HAART resumption after 1 cycle of treatment interruption.","volume":"52","author":"Mussini","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"R22-1-20210130","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","article-title":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys.","volume":"12","author":"Grossman","year":"2006","journal-title":"Nat Med"},{"key":"R23-1-20210130","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1097\/QAD.0b013e3282f2dbe7","article-title":"Immune activation and AIDS pathogenesis.","volume":"22","author":"Sodora","year":"2008","journal-title":"AIDS"},{"key":"R24-1-20210130","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/path.2276","article-title":"Immune activation and inflammation in HIV-1 infection: causes and consequences.","volume":"214","author":"Appay","year":"2008","journal-title":"J Pathol"},{"key":"R25-1-20210130","first-page":"2","article-title":"Pathogenesis of HIV infection: total CD4 T-cell pool, immune activation, and inflammation.","volume":"18","author":"Lane","year":"2010","journal-title":"Top HIV Med"},{"key":"R26-1-20210130","first-page":"2039","article-title":"Availability of activated CD4 T cells dictates the level of viremia in naturally SIV-infected sooty mangabeys.","volume":"118","author":"Klatt","year":"2008","journal-title":"J Clin Invest"},{"key":"R27-1-20210130","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/417095a","article-title":"HIV preferentially infects HIV-specific CD4 T cells.","volume":"417","author":"Douek","year":"2002","journal-title":"Nature"},{"key":"R28-1-20210130","doi-asserted-by":"crossref","first-page":"10900","DOI":"10.1128\/JVI.77.20.10900-10909.2003","article-title":"Diminished proliferation of human immunodeficiency virus-specific CD4 T cells is associated with diminished interleukin-2 (IL-2) production and is recovered by exogenous IL-2.","volume":"77","author":"Iyasere","year":"2003","journal-title":"J Virol"},{"key":"R29-1-20210130","doi-asserted-by":"crossref","first-page":"13747","DOI":"10.1073\/pnas.202372199","article-title":"Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection.","volume":"99","author":"Oxenius","year":"2002","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R30-1-20210130","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1097\/00002030-200007070-00008","article-title":"Pre-HAART HIV burden approximates post-HAART viral levels following interruption of therapy in patients with sustained viral suppression.","volume":"14","author":"Hatano","year":"2000","journal-title":"AIDS"},{"key":"R31-1-20210130","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/ni1180","article-title":"Mechanisms of suppression by suppressor T cells.","volume":"6","author":"von Boehmer","year":"2005","journal-title":"Nat Immunol"},{"key":"R32-1-20210130","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1128\/JVI.78.5.2454-2459.2004","article-title":"Human CD4 CD25 regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens.","volume":"78","author":"Aandahl","year":"2004","journal-title":"J Virol"},{"key":"R33-1-20210130","doi-asserted-by":"crossref","first-page":"E198","DOI":"10.1371\/journal.pbio.0020198","article-title":"HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.","volume":"2","author":"Oswald-Richter","year":"2004","journal-title":"PLoS Biol"},{"key":"R34-1-20210130","doi-asserted-by":"crossref","first-page":"8307","DOI":"10.1128\/JVI.00520-08","article-title":"Preservation of FoxP3 regulatory T cells in the peripheral blood of human immunodeficiency virus type 1-infected elite suppressors correlates with low CD4 T-cell activation.","volume":"82","author":"Chase","year":"2008","journal-title":"J Virol"},{"key":"R35-1-20210130","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1038\/nprot.2006.268","article-title":"Intracellular cytokine optimization and standard operating procedure.","volume":"1","author":"Lamoreaux","year":"2006","journal-title":"Nat Protoc"},{"key":"R36-1-20210130","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-1759(03)00265-5","article-title":"Sensitive and viable identification of antigen-specific CD8 T cells by a flow cytometric assay for degranulation.","volume":"281","author":"Betts","year":"2003","journal-title":"J Immunol Methods"},{"key":"R37-1-20210130","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/cyto.a.20387","article-title":"Subject classification obtained by cluster analysis and principal component analysis applied to flow cytometric data.","volume":"71","author":"Lugli","year":"2007","journal-title":"Cytometry A"},{"key":"R38-1-20210130","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1002\/eji.200737768","article-title":"Polyfunctional T cell responses are a hallmark of HIV-2 infection.","volume":"38","author":"Duvall","year":"2008","journal-title":"Eur J Immunol"},{"key":"R39-1-20210130","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/nature03501","article-title":"Massive infection and loss of memory CD4 T cells in multiple tissues during acute SIV infection.","volume":"434","author":"Mattapallil","year":"2005","journal-title":"Nature"},{"key":"R40-1-20210130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0952-7915(00)00245-4","article-title":"Reconstitution of CD4 T lymphocytes in HIV-infected individuals following antiretroviral therapy.","volume":"13","author":"Carcelain","year":"2001","journal-title":"Curr Opin Immunol"},{"key":"R41-1-20210130","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.4049\/jimmunol.174.6.3143","article-title":"The prevalence of regulatory T cells in lymphoid tissue is correlated with viral load in HIV-infected patients.","volume":"174","author":"Andersson","year":"2005","journal-title":"J Immunol"},{"key":"R42-1-20210130","doi-asserted-by":"crossref","first-page":"e366","DOI":"10.1111\/j.1365-2567.2008.02978.x","article-title":"The decrease of regulatory T cells correlates with excessive activation and apoptosis of CD8 T cells in HIV-1-infected typical progressors, but not in long-term nonprogressors.","volume":"128","author":"Jiao","year":"2009","journal-title":"Immunology"},{"key":"R43-1-20210130","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/eji.200838667","article-title":"High frequency and proliferation of CD4 FOXP3 Treg in HIV-1-infected patients with low CD4 counts.","volume":"39","author":"Bi","year":"2009","journal-title":"Eur J Immunol"},{"key":"R44-1-20210130","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8 T cells.","volume":"107","author":"Betts","year":"2006","journal-title":"Blood"},{"key":"R45-1-20210130","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1128\/JVI.02212-07","article-title":"Virological outcome after structured interruption of antiretroviral therapy for human immunodeficiency virus infection is associated with the functional profile of virus-specific CD8 T cells.","volume":"82","author":"Daucher","year":"2008","journal-title":"J Virol"},{"key":"R46-1-20210130","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1182\/blood-2008-10-182709","article-title":"Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.","volume":"113","author":"Ferre","year":"2009","journal-title":"Blood"},{"key":"R47-1-20210130","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1111\/j.0105-2896.2006.00395.x","article-title":"Functional signatures of protective antiviral T-cell immunity in human virus infections.","volume":"211","author":"Harari","year":"2006","journal-title":"Immunol Rev"},{"key":"R48-1-20210130","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/QAD.0b013e328337b144","article-title":"Cytotoxic granule release dominates gag-specific CD4 T-cell response in different phases of HIV infection.","volume":"24","author":"Nemes","year":"2010","journal-title":"AIDS"},{"key":"R49-1-20210130","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1189\/jlb.0403171","article-title":"Role of CD40 ligand dysregulation in HIV-associated dysfunction of antigen-presenting cells.","volume":"74","author":"Chougnet","year":"2003","journal-title":"J Leukoc Biol"},{"key":"R50-1-20210130","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/nm1293","article-title":"A live-cell assay to detect antigen-specific CD4 T cells with diverse cytokine profiles.","volume":"11","author":"Chattopadhyay","year":"2005","journal-title":"Nat Med"},{"key":"R51-1-20210130","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.4049\/jimmunol.172.4.2678","article-title":"CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription.","volume":"172","author":"Zhang","year":"2004","journal-title":"J Immunol"},{"key":"R52-1-20210130","doi-asserted-by":"crossref","first-page":"3391","DOI":"10.1128\/JVI.02383-07","article-title":"Emergence of polyfunctional CD8 T cells after prolonged suppression of human immunodeficiency virus replication by antiretroviral therapy.","volume":"82","author":"Rehr","year":"2008","journal-title":"J Virol"}],"container-title":["AIDS"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/journals.lww.com\/00002030-201107310-00001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T07:14:24Z","timestamp":1618038864000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00002030-201107310-00001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,31]]},"references-count":52,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/qad.0b013e328347b5e2","relation":{},"ISSN":["0269-9370"],"issn-type":[{"value":"0269-9370","type":"print"}],"subject":[],"published":{"date-parts":[[2011,7,31]]}}}